bSix different Treponema (TP)-specific immunoassays were compared to the fluorescent treponemal antibody absorption (FTA-ABS) test. A total of 615 samples were tested. The overall percent agreement, analytical sensitivity, and analytical specificity of each assay compared to the FTA-ABS test were as follows: Architect Syphilis TP, 99.2%, 96.8%, and 100%; Cobas Syphilis, 99.8%, 99.4%, and 100%; ADVIA Centaur Syphilis, 99.8%, 99.4%, and 100%; HISCL Anti-TP assay kit, 99.7%, 98.7%, and 100%; Immunoticles Auto3 TP, 99.0%, 97.5%, and 99.6%; Mediace TPLA, 98.0%, 98.1%, and 98.0%. All results that were discrepant between the TP-specific assays were associated with samples from noninfectious cases (11 immunoassay false positives and 7 from previous syphilis cases). Our study demonstrated that TP-specific immunoassays generally showed high sensitivities, specificities, and percentages of agreement compared to FTA-ABS, with rare cases of false-positive or false-negative results. Therefore, most TPspecific immunoassays are acceptable for use in screening for syphilis. However, it is important to perform a thorough review of a patient's clinical and treatment history for interpreting the results of syphilis serology.
Syphilis is commonly diagnosed on the basis of the results of a combination of serological tests to detect Treponema (TP) antibodies and non-TP antibodies (1). A traditional screening algorithm for syphilis that began with a non-TP assay failed to detect 3% of syphilis cases, in a previous study (2). Recently, a reversescreening algorithm with an automated TP-specific assay has been recommended by the European Centers for Disease Control and Prevention (ECDC) (3). CDC continues to recommend the traditional algorithm and yet also recognizes the recent trend of the widespread use of the reverse algorithm and recommends extra TP tests to resolve discordant results (4). The reverse algorithm has been found to show superior diagnostic performance, with sensitivities ranging from 99.38% to 99.85%, specificities from 99.98% to 100%, and accuracies from 99.93% to 99.96% compared with a 24.2% missed-diagnosis rate and 75.81% sensitivity of the traditional algorithm (5).Various automated TP-specific immunoassays have been developed that use either whole cells or antigens, such as 15TpN, 17TpN, and 47TpN, derived from the Nichols strain of Treponema pallidum, to detect IgG, IgM, or total immunoglobulins (1). Initially, enzyme immunoassays (EIAs) were commonly used to detect TP-specific antibodies (5, 6). However, the use of chemiluminescence immunoassays (CLIAs) to detect TP-specific IgG and IgM antibodies has been gradually increasing (6, 7). Additionally, quantitative TP-specific immunoassays using turbidimetry, based on a latex agglutination method, have been widely used in Asia. However, comparative analyses of the performances of these various methods are lacking.The aim of this study was to evaluate the performances of 6 commonly used TP-specific immunoassays, including CLIAs and turbidimetry assays, in comparison w...